caffeine ...and Alzheimer and Parkinson

 

Most people drink coffee to feel more alert.

But new research published in the journal Clinical Neurophysiology

reveals that caffeine is doing something far more specific inside the brain —

and the discovery has direct implications for how neurological conditions like

Alzheimer's and Parkinson's

are diagnosed and monitored.

The study, conducted by researchers at Campus Bio-Medico University of Rome, examined

how caffeine equivalent to approximately

two cups of coffee affects

the brain's sensory-motor inhibition system

the neurological mechanism by which incoming sensory signals temporarily suppress outgoing movement commands.

Using transcranial magnetic stimulation, researchers measured this braking system in twenty healthy adults on two separate occasions

— once after consuming 200 milligrams of caffeine and once after a placebo —

in a controlled double-blind experiment.

The findings showed that caffeine significantly enhanced the brain's ability to suppress its own motor signals in response to sensory input.

This effect peaked at a very specific timing window of 19 to 21 milliseconds between the sensory signal and the motor stimulus — suggesting caffeine acts on precise and targeted neural circuits rather than simply elevating general brain activity across the board.

The researchers attribute this effect to caffeine's ability to block adenosine receptors, which in turn increases the release of acetylcholine —

a neurotransmitter that plays a central role in this inhibitory braking system.

This same cholinergic network is one of the first systems damaged in Alzheimer's disease, and its gradual deterioration is also seen in Parkinson's disease.

The clinical implication is significant.

Because caffeine measurably alters these neurological test readouts, patients should abstain from coffee before undergoing these specific brain assessments.

Consuming caffeine before testing could mask underlying abnormalities or produce inaccurate diagnostic results.

Researchers also noted that caffeine's ability to boost the same chemical pathways that neurodegeneration destroys makes it a potentially valuable tool for refining how doctors track cognitive decline over time.